Quadriceps strength is a sensitive marker of disease progression in sporadic inclusion body myositis

Neuromuscular Disorders

Volumn 22, Issue 11, 2012, Pages 980-986

  Allenbach, Yves ^a   Benveniste, Olivier ^a   Decostre, Valérie ^b   Canal, Aurélie ^b   Eymard, Bruno ^a   Herson, Serge ^a   Bloch Queyrat, Coralie ^a   Hogrel, Jean Yves ^b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Dynamometry; Inclusion body myositis; Natural history; Outcome measures; Strength

Indexed keywords

AGED; ANKLE; ARTICLE; CLINICAL ARTICLE; DISEASE COURSE; DISEASE DURATION; DISEASE MARKER; DYNAMOMETRY; ELBOW FLEXION; FEMALE; HAND GRIP; HUMAN; INCLUSION BODY MYOSITIS; KNEE FUNCTION; MALE; MUSCLE FUNCTION; MUSCLE STRENGTH; MUSCLE WEAKNESS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SPORADIC INCLUSION BODY MYOSITIS; WRIST;

DISEASE PROGRESSION; FEMALE; HAND STRENGTH; HUMANS; KNEE JOINT; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; MUSCLE, SKELETAL; MYOSITIS, INCLUSION BODY; QUADRICEPS MUSCLE;

EID: 84868110471     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2012.05.004     Document Type: Article

References (18)

1. Dalakas M.C. Inflammatory, immune, and viral aspects of inclusion-body myositis. Neurology 2006, 66:S33-S38.
2. Askanas V., Engel W.K. Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains. Acta Neuropathol 2008, 116:583-595.
3. Benveniste O., Guiguet M., Freebody J., Dubourg O., Squier W., Maisonobe T., et al. Long-term observational study of sporadic inclusion body myositis. Brain 2011, 134:3176-3184.
4. Lindberg C., Persson L.I., Bjorkander J., Oldfors A. Inclusion body myositis: clinical, morphological, physiological and laboratory findings in 18 cases. Acta Neurol Scand 1994, 89:123-131.
5. Dalakas M.C., Rakocevic G., Schmidt J., et al. Effect of Alemtuzumab (CAMPATH 1-H) in patients with inclusion-body myositis. Brain 2009, 132:1536-1544.
6. Rose M.R., McDermott M.P., Thornton C.A., Palenski C., Martens W.B., Griggs R.C. A prospective natural history study of inclusion body myositis: implications for clinical trials. Neurology 2001, 57:548-550.
7. Griggs R.C., Askanas V., DiMauro S., Engel A., Karpati G., Mendell J.R., et al. Inclusion body myositis and myopathies. Ann Neurol 1995, 38:705-713.
8. Walton J., Karpati G., Hilton-Jones D. Disorders of voluntary muscle 1994, Churchill Livingstone, Edinburgh.
9. Collen F.M., Wade D.T., Robb G.F., Bradshaw C.M. The Rivermead Mobility Index: a further development of the Rivermead Motor Assessment. Int Disabil Stud 1991, 13:50-54.
10. Jackson C.E., Barohn R.J., Gronseth G., Pandya S., Herbelin L. Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle Nerve 2008, 37:473-476.
11. Li K., Hewson D.J., Duchene J., Hogrel J.Y. Predicting maximal grip strength using hand circumference. Man Ther 2010, 15:579-585.
12. Enright P.L., Sherrill D.L. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998, 158:1384-1387.
13. Hogrel J.Y., Payan C.A., Ollivier G., Tanant V., Attarian S., Couillandre A., et al. Development of a French isometric strength normative database for adults using quantitative muscle testing. Arch Phys Med Rehabil 2007, 88:1289-1297.
14. Badrising U.A., Maat-Schieman M.L., van Houwelingen J.C., van Doorn P.A., van Duinen S.G., van Engelen B.G., et al. Inclusion body myositis. Clinical features and clinical course of the disease in 64 patients. J Neurol 2005, 252:1448-1454.
15. Needham M., James I., Corbett A., Day T., Christiansen F., Phillips B., et al. Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry 2008, 79:1056-1060.
16. Johnson L.G., Collier K.E., Edwards D.J., Philippe D.L., Eastwood P.R., Walters S.E., et al. Improvement in aerobic capacity after an exercise program in sporadic inclusion body myositis. J Clin Neuromuscul Dis 2009, 10:178-184.
17. Bernhardt K.A., Oh T.H., Kaufman K.R. Gait patterns of patients with inclusion body myositis. Gait Posture 2011, 33:442-446.
18. Lowes L.P., Alfano L., Viollet L., Quintero Rosales X., Sahenk Z., Kaspar B.K., et al. Knee extensor strength exhibits potential to predict function in sporadic inclusion-body myositis. Muscle Nerve 2012, 45:163-168.